|
G
|
Ahr
|
aryl hydrocarbon receptor
|
increases expression
|
ISO
|
Tryptophan results in increased expression of AHR mRNA
|
CTD |
PMID:32781018 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
G
|
App
|
amyloid beta precursor protein
|
multiple interactions decreases abundance
|
ISO
|
PF-06840003 inhibits the reaction [APP protein mutant form results in decreased abundance of Tryptophan]
|
CTD |
PMID:39172838 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions increases expression
|
ISO
|
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Tryptophan co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1A1 mRNA]; [Tryptophan co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1A1 mRNA Tryptophan results in increased expression of CYP1A1 mRNA
|
CTD |
PMID:32781018 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
multiple interactions increases expression
|
ISO
|
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Tryptophan co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1B1 mRNA]; [Tryptophan co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1B1 mRNA Tryptophan results in increased expression of CYP1B1 mRNA
|
CTD |
PMID:32781018 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
G
|
Ido1
|
indoleamine 2,3-dioxygenase 1
|
increases expression increases abundance
|
ISO
|
Tryptophan results in increased expression of IDO1 protein IDO1 gene mutant form results in increased abundance of Tryptophan
|
CTD |
PMID:32781018 PMID:32871117 |
|
NCBI chr16:74,133,259...74,145,328
Ensembl chr16:74,133,259...74,145,328
|
|
G
|
Ifng
|
interferon gamma
|
multiple interactions
|
ISO
|
IFNG protein promotes the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]]; IFNG protein promotes the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]]
|
CTD |
PMID:32781018 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
G
|
Igfbp1
|
insulin-like growth factor binding protein 1
|
increases expression multiple interactions
|
ISO
|
Tryptophan results in increased expression of IGFBP1 mRNA 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]]; IFNG protein promotes the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]]; Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]
|
CTD |
PMID:32781018 |
|
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344
|
|
G
|
Mapt
|
microtubule-associated protein tau
|
multiple interactions
|
ISO
|
[amyloid beta-protein (1-42) binds to MAPT protein] which results in decreased abundance of Tryptophan [amyloid beta-protein (1-42) binds to MAPT protein] which results in decreased abundance of Tryptophan; PF-06840003 inhibits the reaction [[amyloid beta-protein (1-42) binds to MAPT protein] which results in decreased abundance of Tryptophan]
|
CTD |
PMID:39172838 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
G
|
Prl
|
prolactin
|
multiple interactions increases expression
|
ISO
|
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]]; IFNG protein promotes the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]]; Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA] Tryptophan results in increased expression of PRL mRNA
|
CTD |
PMID:32781018 |
|
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217
|
|
G
|
Slc7a5
|
solute carrier family 7 member 5
|
increases expression
|
ISO
|
Tryptophan results in increased expression of SLC7A5 mRNA
|
CTD |
PMID:32781018 |
|
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412
|
|
G
|
Tdo2
|
tryptophan 2,3-dioxygenase
|
increases abundance
|
ISO
|
TDO2 gene mutant form results in increased abundance of Tryptophan
|
CTD |
PMID:32871117 |
|
NCBI chr 2:169,567,656...169,585,586
Ensembl chr 2:169,567,654...169,585,586
|
|
G
|
Tph1
|
tryptophan hydroxylase 1
|
multiple interactions
|
EXP
|
[TPH1 protein results in increased hydroxylation of Tryptophan] which results in increased chemical synthesis of 5-Hydroxytryptophan
|
CTD |
PMID:32243540 |
|
NCBI chr 1:106,293,695...106,314,628
Ensembl chr 1:106,085,953...106,312,484
|
|
|
G
|
Il13
|
interleukin 13
|
multiple interactions
|
EXP
|
ilomastat inhibits the reaction [Mustard Gas results in increased expression of IL13 protein]
|
CTD |
PMID:18852015 |
|
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
|
|
G
|
Mmp1
|
matrix metallopeptidase 1
|
multiple interactions
|
EXP
|
ilomastat affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MMP1 protein]; ilomastat inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MMP1 mRNA]
|
CTD |
PMID:18837084 |
|
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
multiple interactions
|
EXP
|
ilomastat affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TIMP1 mRNA]; ilomastat affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TIMP1 protein]
|
CTD |
PMID:18837084 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
|
G
|
Ache
|
acetylcholinesterase
|
multiple interactions
|
EXP
|
N-acetyltryptophan inhibits the reaction [Aluminum Chloride results in decreased activity of ACHE protein]
|
CTD |
PMID:29185389 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
G
|
Casp2
|
caspase 2
|
multiple interactions
|
ISO
|
N-acetyltryptophan inhibits the reaction [Cobalt-60 results in increased activity of CASP2 protein]
|
CTD |
PMID:37702290 |
|
NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions
|
ISO
|
N-acetyltryptophan inhibits the reaction [Cobalt-60 results in increased activity of CASP3 protein]
|
CTD |
PMID:37702290 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions
|
ISO
|
N-acetyltryptophan inhibits the reaction [Cobalt-60 results in increased activity of CASP9 protein]
|
CTD |
PMID:37702290 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Cat
|
catalase
|
multiple interactions
|
ISO
|
N-acetyltryptophan inhibits the reaction [Cobalt-60 results in decreased activity of CAT protein]
|
CTD |
PMID:37702290 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Xdh
|
xanthine dehydrogenase
|
multiple interactions
|
ISO
|
N-acetyltryptophan inhibits the reaction [Cobalt-60 results in increased activity of XDH protein]
|
CTD |
PMID:37702290 |
|
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
|
G
|
Casp2
|
caspase 2
|
increases activity
|
ISO
|
violacein results in increased activity of CASP2 protein
|
CTD |
PMID:20416285 |
|
NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022
|
|
G
|
Casp3
|
caspase 3
|
increases activity
|
ISO
|
violacein results in increased activity of CASP3 protein
|
CTD |
PMID:20416285 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp9
|
caspase 9
|
increases activity
|
ISO
|
violacein results in increased activity of CASP9 protein
|
CTD |
PMID:20416285 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|